कृपया अन्य खोज का प्रयास करें
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Linda F. Powers | 65 | 2007 | Chairperson, CEO, President, CFO & Chief Accounting Officer |
Alton L. Boynton | 76 | 1998 | Founder, Chief Scientific Officer, Secretary & Director |
Steven S. Brem | - | 2005 | Member of Clinical Advisory Board |
J. Cofer Black | 74 | 2016 | Independent Director |
Tom Mikkelsen | - | 2005 | Member of Clinical Advisory Board |
Navid Malik | 55 | 2012 | Independent Director |
Henry Brem | 71 | 2005 | Member of Clinical Advisory Board |
Darell D. Bigner | - | 2005 | Member of Clinical Advisory Board |
Linda M. Liau | 57 | 2005 | Member of Scientific Advisory Board |
Jerome Galon | - | - | Member of Scientific Advisory Board |
Samir N. Khleif | 60 | - | Member of Scientific Advisory Board |
Martin Cheever | 80 | - | Member of the Scientific Advisory Board |
John F. Smyth | - | - | Member of Scientific Advisory Board |
Pat Sarma | - | 2024 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है